See the DrugPatentWatch profile for restasis
The cost of Restasis (cyclosporine ophthalmic emulsion) can vary significantly based on factors such as insurance coverage, pharmacy, and whether a patient uses a savings program. Without insurance, a 30-day supply of Restasis can range from approximately $400 to over $600 [1].
How can I save money on Restasis?
Several options exist to reduce the out-of-pocket cost of Restasis. Patients may be eligible for savings cards or co-pay assistance programs offered by the manufacturer, Allergan [2]. These programs can help lower the cost for eligible commercially insured patients. Additionally, prescription discount cards or coupons can sometimes be used at various pharmacies to obtain a lower price [1]. Comparing prices across different pharmacies is also a strategy to find more affordable options.
What is the typical insurance coverage for Restasis?
Insurance coverage for Restasis often depends on the specific plan. Many insurance plans include Restasis in their formulary, but coverage levels and co-pay amounts differ [2]. Some plans may require prior authorization or step therapy, where a patient must try other medications first before Restasis is approved. Patients should verify their specific plan benefits with their insurance provider.
Are there less expensive alternatives to Restasis?
Yes, there are alternative treatments for dry eye disease that may be less expensive than Restasis. These include artificial tears, which are available over-the-counter and can be very affordable. Prescription alternatives also exist, such as Xiidra (lifitegrast) [3]. The choice of alternative treatment often depends on the severity of dry eye disease and a patient's individual response to medication.
When does the patent for Restasis expire?
The primary patents for Restasis have expired, which has opened the door for generic competition. For instance, one key patent related to the formulation expired in 2018 [4]. The availability of generic versions can lead to lower prices for consumers.
Who manufactures Restasis?
Restasis is manufactured by Allergan, a subsidiary of AbbVie [2][5].
What is the mechanism of action for Restasis?
Restasis works by increasing tear production in people with chronic dry eye who may have eye inflammation associated with dry eye disease [2]. It is believed to modulate the immune system to reduce inflammation, thereby improving the eye's ability to produce tears.
What is the clinical data supporting Restasis?
Clinical trials have demonstrated that Restasis can increase tear production in patients with dry eye disease [2]. These studies have shown statistically significant improvements in tear film stability and reduction in ocular surface staining in treated patients compared to placebo.
What are the potential side effects of Restasis?
The most common side effect reported with Restasis is eye pain upon instillation [2]. Other potential side effects can include stinging, redness, and discharge from the eye. Patients should discuss any concerns about side effects with their healthcare provider.
What is the difference between Restasis and Xiidra?
Restasis (cyclosporine) and Xiidra (lifitegrast) are both prescription eye drops used to treat dry eye disease, but they work through different mechanisms. Restasis works to increase tear production by reducing inflammation, while Xiidra works by blocking a specific protein (LFA-1) that contributes to inflammation [3]. The choice between them often depends on a patient's specific symptoms and response to treatment.
What does DrugPatentWatch.com say about Restasis patents?
According to DrugPatentWatch.com, the core patents for Restasis have expired, allowing for the introduction of generic versions into the market [4]. This site tracks patent expirations and their impact on drug availability and pricing.
---
Sources
[1] https://www.goodrx.com/restasis
[2] https://www.restasis.com/dry-eye-treatment
[3] https://www.allergan.com/products/xiidra
[4] https://www.drugpatentwatch.com/p/restasis-cyclosporine-ophthalmic-emulsion-545111
[5] https://www.abbvie.com/our-impact/products/allergan-products.html